Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05297500 · ClinicalTrials.gov registry record
Determination of SpO2 and PR Accuracy Specifications at Rest (71Ag_Vital-0031)
A clinical trial of Hypoxia, sponsored by Nihon Kohden.
- Active
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT05297500: Active study of Hypoxia, sponsored by Nihon Kohden.
NCT05297500 is a study of Hypoxia that is active but no longer recruiting, run by Nihon Kohden. The registered enrollment target is 12 participants, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05297500, a study of Hypoxia, is active but no longer recruiting, sponsored by Nihon Kohden.
- ACTIVE NOT RECRUITING
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients at rest
Primary Outcome
Each subject will have an arterial catheter inserted in the left or right wrist and the pulse oximeter study device placed on different fingers of the left or right hand, or the left or right earlobe or the forehead. Measurement position is randomized across subjects. For each subject, a series of desaturation runs are performed. Run 1 stabilized room air period -\> stabilized plateaus at saturation level targets: room air, 92%, 87%, 82%, 77%, 72% Run 2 stabilized 100% O2 period -\> stabilize
Conditions Studied
Interventions
- DEVICE Pulse oximeter
Study Locations (1)
California
- UCSF Hypoxia Research Laboratory - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-03-23 |
| Est. Completion | 2026-10-29 |
What the registry record for NCT05297500 still lists
NCT05297500 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Pulse oximeter is the first listed.
NCT05297500 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05297500 about?
NCT05297500 is a clinical study titled "Determination of SpO2 and PR Accuracy Specifications at Rest (71Ag_Vital-0031)". The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients at rest
What is the current status of trial NCT05297500?
This trial is currently active not recruiting. The enrollment target is 12 participants. The study started on 2022-03-23. Estimated completion is 2026-10-29.
What conditions does trial NCT05297500 study?
This clinical trial studies the following conditions: Hypoxia.
What interventions are being tested in trial NCT05297500?
The interventions under investigation include: Pulse oximeter (DEVICE).
Who is sponsoring clinical trial NCT05297500?
This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05297500 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05297500's enrollment target sits among peer trials
12 30th of 39 higher than 3 of 39 other Hypoxia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Intravenous Iron Effects on Performance at High Altitude
RECRUITING · Phase 4
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
RECRUITING · Phase 2
-
Pulse Oximeter Accuracy in Healthy Humans During Hypoxia
RECRUITING
-
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI